Rubius Therapeutics Inc

NASDAQ:RUBY   3:59:59 PM EDT
28.03
+1.16 (+4.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Rubius Therapeutics Inc Stock, NASDAQ:RUBY

399 Binney Street, Suite 300, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.679.9600
Number of Employees: 204

Description

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.